Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 7
1979 6
1980 2
1981 12
1982 13
1983 23
1984 18
1985 35
1986 45
1987 38
1988 41
1989 76
1990 63
1991 90
1992 74
1993 94
1994 88
1995 89
1996 120
1997 149
1998 205
1999 166
2000 255
2001 230
2002 322
2003 294
2004 311
2005 313
2006 350
2007 369
2008 379
2009 444
2010 479
2011 521
2012 509
2013 563
2014 589
2015 654
2016 678
2017 733
2018 727
2019 843
2020 1058
2021 1363
2022 1432
2023 1493
2024 681

Text availability

Article attribute

Article type

Publication date

Search Results

15,398 results

Results by year

Filters applied: . Clear all
Page 1
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease.
Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A. Budd Haeberlein S, et al. J Prev Alzheimers Dis. 2022;9(2):197-210. doi: 10.14283/jpad.2022.30. J Prev Alzheimers Dis. 2022. PMID: 35542991 Clinical Trial.
Alzheimer's disease: Recent treatment strategies.
Vaz M, Silvestre S. Vaz M, et al. Eur J Pharmacol. 2020 Nov 15;887:173554. doi: 10.1016/j.ejphar.2020.173554. Epub 2020 Sep 15. Eur J Pharmacol. 2020. PMID: 32941929 Review.
Lecanemab: First Approval.
Hoy SM. Hoy SM. Drugs. 2023 Mar;83(4):359-365. doi: 10.1007/s40265-023-01851-2. Drugs. 2023. PMID: 36856953 Review.
Alzheimer's Disease Treatment: The Search for a Breakthrough.
Reiss AB, Muhieddine D, Jacob B, Mesbah M, Pinkhasov A, Gomolin IH, Stecker MM, Wisniewski T, De Leon J. Reiss AB, et al. Medicina (Kaunas). 2023 Jun 4;59(6):1084. doi: 10.3390/medicina59061084. Medicina (Kaunas). 2023. PMID: 37374288 Free PMC article. Review.
15,398 results
You have reached the last available page of results. Please see the User Guide for more information.